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Abstract
Background: Hydrocephalus in Friesian horses is a developmental disorder that often results in stillbirth of affected
foals and dystocia in dams. The occurrence is probably related to a founder effect and inbreeding in the population.
The aim of our study was to find genomic associations, to investigate the mode of inheritance, to allow a DNA test for
hydrocephalus in Friesian horses to be developed. In case of a monogenic inheritance we aimed to identify the
causal mutation.
Results: A genome-wide association study of hydrocephalus in 13 cases and 69 controls using 29,720 SNPs
indicated the involvement of a region on ECA1 (P <1.68 × 10−6). Next generation DNA sequence analysis of 4
cases and 6 controls of gene exons within the region revealed a mutation in β-1,3-N-acetylgalactosaminyltransferase 2
(B3GALNT2) as the likely cause of hydrocephalus in Friesian horses. The nonsense mutation XM_001491545 c.1423C>T
corresponding to XP_001491595 p.Gln475* was identical to a B3GALNT2 mutation identified in a human case of
muscular dystrophy-dystroglycanopathy with hydrocephalus. All 16 available cases and none of the controls were
homozygous for the mutation, and all 17 obligate carriers (= dams of cases) were heterozygous. A random sample of
the Friesian horse population (n = 865) was tested for the mutation in a commercial laboratory. One-hundred and
forty-seven horses were carrier and 718 horses were homozygous for the normal allele; the estimated allele frequency
in the Friesian horse population is 0.085.
Conclusions: Hydrocephalus in Friesian horses has an autosomal recessive mode of inheritance. A nonsense mutation
XM_001491545 c.1423C>T corresponding to XP_001491595 p.Gln475* in B3GALNT2 (1:75,859,296–75,909,376) is
concordant with hydrocephalus in Friesian horses. Application of a DNA test in the breeding programme will reduce
the losses caused by hydrocephalus in the Friesian horse population.
Keywords: Hydrocephalus, B3GALNT2, Genome-wide association study, Next generation sequencing, Friesian horse,
Muscular dystrophy
Background
The Friesian horse breed originates from the Netherlands
and is characterized by its specific appearance, gaits, ver-
satility and character. Although the current size of the
population is quite large, a small population size during
certain periods in the past, combined with unequal genetic
contribution of influential ancestors in a closed popula-
tion, resulted in an inbreeding rate of 1.5 % per generation
computed from pedigree data [1]. The computed inbreed-
ing rate exceeds the FAO limit [2] of 1 % per generation,
which is set to maintain the remaining genetic variation in
a breed and by that limit the potential negative effects of
inbreeding. Especially when caused by unequal genetic
contribution, inbreeding can result in inbreeding depres-
sion and a higher incidence of genetic defects [3]. One
such genetic defect that seems to occur predominantly in
Friesian horses is congenital hydrocephalus [OMIA
000487-9796; [4–6]], although a few cases have been
reported in other horse breeds like Standardbred trotters,
Orlov trotters, a Finnish horse [7], American Miniature
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horses [8], Hanoverian warmblood horses [9] and Thor-
oughbred horses [10].
Hydrocephalus is defined as “an active distension of
the ventricular system of the brain resulting from inad-
equate passage of cerebrospinal fluid (CSF) from its
point of production within the cerebral ventricles to its
point of absorption into the systemic circulation” [11].
Hydrocephalus can be acquired, e.g. due to infection or
trauma, or can be hereditary in nature. To our best know-
ledge, no clear cases of a proven acquired hydrocephalus
in horses have been reported in scientific literature. Dif-
ferent types of hydrocephalus have been identified
based on the underlying mechanisms: communicating
(increased production or impaired CSF absorption) or
non-communicating (obstruction in CSF flow) [11].
Also, hydrocephalus can be internal or external, that is
an accumulation of CSF respectively within or outside
the ventricles of the brain. In horses, both external and
internal hydrocephalus [7, 8] have been diagnosed. A
Hannoverian foal affected with both internal and external
hydrocephalus was reported as well [9]. Sipma et al. [6]
examined 4 stillborn Friesian foals with hydrocephalus
both macroscopically and microscopically and compared
these affected foals with 2 unaffected stillborn Friesian
foals. Noticeable on the outside of affected foals was the
severe cranial distension. The most likely cause of hydro-
cephalus in Friesian horses, based on the findings from
the examinations of these 4 foals, was an abnormal nar-
rowing (stenosis) of the jugular foramen, suggesting “a
communicative (external) hydrocephalus with a dimin-
ished absorption of cerebrospinal fluid into the systemic
circulation at the venous sinuses due to a distorted, non-
functional jugular foramen” [6]. Hydrocephalus also has
been associated with dystocia in dams and can eventually
lead to fatal complications for the dam at parturition
[7, 8, 12]. Affected foals are often stillborn or are eutha-
nized at birth to facilitate parturition. The incidence of
hydrocephalus was 3.0 % in a population of 608 de-
formed fetuses or new-born foals, mostly Thorough-
breds, that were submitted for necropsy [13].
In humans, about 40 % of hydrocephalus cases have
a known genetic cause according to the Online Mendelian
Inheritance in Man (OMIM) database. Genetic heteroge-
neity of congenital hydrocephalus is observed: mutations
in the CCDC88C gene [MIM:611204] on chromosome 14
[14, 15] and in the MPDZ gene [MIM:603785] on
chromosome 9 [16] are responsible for autosomal reces-
sive hydrocephalus (respectively HYC1 [MIM:236600] and
HYC2 [MIM:615219]). The most common form of con-
genital hydrocephalus in humans (5 to 15 % of patients) is
the X-linked recessive form caused by a mutation in
L1CAM ([MIM:308840]; e.g. [17]; HSAS1 [MIM:307000]).
Moreover, heterogeneity among phenotypes exists in
humans as well as in animals [18]. To our best knowledge,
research on the genetic background of hydrocephalus in
horses is very limited. Ojala and Ala-Huikku [7] reported
10 foals with internal hydrocephalus of which 7 foals des-
cended from the same Standardbred trotter stallion. This
stallion was also the sire of a dam that aborted an affected
foetus. A pedigree analysis was performed to determine
the possible mode of inheritance (autosomal recessive,
dominant or X-linked). The most likely cause of internal
hydrocephalus in Standardbred trotters was a dominant
mutation. The aim of our study was to find genomic asso-
ciations, to investigate the mode of inheritance, to allow a
DNA test for hydrocephalus in Friesian horses to be de-
veloped. In case of a monogenic inheritance we aimed to
identify the causal mutation. Knowing the mutation will
help in understanding the aetiology of hydrocephalus and
allow selection against the disease allele using a DNA test.
In our study, we identified a mutation concordant with
hydrocephalus in Friesian horses using genotype and se-
quence data from affected and unaffected horses.
Methods
Phenotypes and horses
Phenotypic diagnosis of cases (n = 16) of hydrocephalus
in Friesian horses was performed by local veterinarians.
Controls (n = 89) were Friesian horses without the typ-
ical phenotypic appearance of hydrocephalus and in-
cluded 17 dams of cases.
Cases and controls were born between 1995 and
2009. Stallions, geldings and mares were represented in
the controls, while the gender of the cases was un-
known. Paternal half-sib relationships were present be-
tween some of the cases, between some of the controls
and also between some of the cases and controls. The
pedigree information of several horses, however, turned
out to be questionable, as large discrepancies were ob-
served between pedigree relationship (A, according to
Colleau [19]) and genomic relationship (G, according to
VanRaden [20]) among horses calculated with calc_grm
software [21] (data not shown). Relationships were not
included in the analyses, but rather in the design phase
of the project by choosing related controls for the cases.
Samples, genotypes and quality control
Most of the control samples (n = 69) were obtained
during treatment at the Equine Clinic of Utrecht University
for reasons other than hydrocephalus. The remaining
control samples were collected by the studbook dur-
ing inspections, where paternal half-sibs of cases were
sought. All samples were collected with permission of
the horse’s owner (informed consent). Blood samples
from controls were collected by jugular venepuncture
in 10 ml blood collection tubes (Heparin or EDTA).
DNA isolation from heparinized blood samples was
performed as described by Orr et al. [22]. DNA
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isolation from blood samples collected in EDTA tubes
was performed using the Gentra® Puregene® Kit from
QIAGEN© according to the manufacturer’s instruc-
tions. Samples from cases were voluntarily submitted
by private owners through their local veterinarian to
Utrecht University, which was facilitated by the studbook.
DNA from cases was extracted from tissue samples (mostly
ear, but also leg or spleen). Cases were patients of privately
owned clinics and samples from controls were collected
with informed consent of the horse’s owner. It was consid-
ered that there was no need for an Animal Care and Ethics
Committee approval according to the Dutch law.
Genotypes of 13 cases and 69 controls (including 3
dams of cases) were obtained using the Illumina®
EquineSNP50 Genotyping BeadChip containing 54,602
SNPs distributed evenly across the genome. SNPs with
a minor allele frequency (MAF) <5 % and call-rate <90 %
were discarded using the check.marker function in the
GenABEL package in R [23]. Also, minimum call-rate per
horse was set at 90 %. Almost all discarded SNPs (92.6 %)
had MAF <5 %. In total 29,720 SNPs (54.4 % of all SNPs
present on the BeadChip) were used in the analysis. Mean
call-rate per horse after quality control was 99.6 %, and
ranged from 91.3 to 99.97 %.
Statistical analyses
The significance level of differences in genotype fre-
quencies between cases and controls per SNP was de-
termined with a χ2-test from 2 × 3 (genotypic) tables
using the ccfast function in the GenABEL package in R
[23]. The conservative Bonferroni corrected significance
level was 1.68 × 10−6 (¼ α n= , where α was the desired sig-
nificance level being 0.05 and n was the number of SNPs
(n≡ 29,720) that were tested).
Individual genotypes of cases and controls from all
SNPs in the significantly associated region (60 to 90 Mb
on ECA1) were visualized to allow an examination of
the associated region to identify overlapping regions of
homozygosity (identical-by-state) between cases.
Next generation DNA sequence analysis
The procedures of the next generation sequencing were
as described earlier [24, 25] and were performed by a
designated laboratory of Utrecht University (Hubrecht
Institute, Utrecht, the Netherlands). The exons and ad-
jacent 20 bp of the genes in the region of interest were
selected from the EquCab2.0 genome (Broad Institute,
Cambridge, MA, USA) to design a Sure-Select slide
(Agilent Technologies). The DNA of 4 randomly selected
cases and 6 controls was sheared by sonication, tagged
with individual DNA barcodes and pooled. These pools
were size fractionated by gel electrophoresis. Fragments of
180–220 bp were excised and purified. The DNA was
enriched for the selected exons by hybridization with the
custom slide and sequenced using the SOLiD version
5500 system (Life Technologies).
DNA sequencing reads were mapped against the
EquCab2.0 reference genome using BWA [26]. Only
reads that were unambiguously mapped were used for
variant calling by our custom caller. Briefly, variants
were only considered if supported by ≥3 unique reads,
when present at least 1× in the first 25 bases of a read (i.e.
the region of a read that binds most accurately the target
of interest, and has the highest sequencing quality), with a
raw coverage ≥10×, base quality score ≥20 and a percent-
age of non-reference alleles ≥15 %.
Sanger DNA sequencing
Due to its high GC content, exon 1 of B3GALNT2 was
not represented on the enrichment array and therefore
not covered by the next generation sequencing experi-
ment. For variant discovery, exon 1 was analysed by
Sanger DNA sequencing in cases and controls. The PCR
primer sequences were CAAGCCGACGTCAGCAGCAT
and TTTCGTCTGGGGACCGTCGT. Amplification of
exon 1 was performed using PCR-mix containing 1× Q5®
Reaction Buffer, 1× Q5® High GC Enhancer, 1 M Betaine,
dNTPs 0.2 mM each, 0.5 μM of each primer, 0.5 Unit Q5®
Hot Start High-Fidelity DNA polymerase (New England
Biolabs) and 50 ng of gDNA in a reaction volume of 15 μl.
The thermal cycling protocol consisted of 30 s 98 °C
followed by 40 cycles of 10 s at 98 °C, 30 s at 60 °C, 45 s at
72 °C, and a final elongation step at 72 °C for 2 min.
After identification of the candidate causal mutation,
16 available cases, 51 controls and 17 obligate carriers
(dams of cases) were genotyped by Sanger sequencing
for validation (Additional file 1). For this genotyping by
sequencing step, PCR was performed with primers
GTATGCATGCTCTCCGTCTT and AGTGCCAGGCC
TAGAACTAT with 50 ng genomic DNA, 3 U Platinum
Taq DNA polymerase (Invitrogen), 2 mM MgCl2, 0.2 mM
each dNTP, 0.5 μM each primer and 1× Platinum buffer.
Temperature cycling conditions were 5 min at 95 °C,
40 cycles of 30 s at 95 °C, 30 s at 55 °C, 30 s at 72 °C, and
a final elongation step at 72 °C for 10 min. All amplifica-
tions were performed on an ABI 9700 Thermal Cycler
(Applied Biosystems, Foster City, CA). DNA sequencing
tercycle reactions were performed in the presence of 1 M
Betaine using BigDye v3.1 (Applied Biosystems, Life Tech-
nologies) according to the manufacturer’s protocol. The
products were analysed on a 3130XL Genetic Analyzer
(Applied Biosystems, Life Technologies) and the data was
analysed with Lasergene (version 11 DNASTAR).
Population screening
A DNA test for the candidate causal mutation has been
developed to be able to genotype broodmares and
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stallions and is now available at a commercial laboratory.
Until now, 805 mares and 60 stallions have been tested.
Linkage disequilibrium
Linkage disequilibrium (LD, as squared correlation coef-
ficient r2 [27]) between SNPs and between SNPs and the
mutation was calculated using Haploview 4.2 [28].
Results
Associated SNPs and homozygosity
The genome-wide association study implicated a region
on Equus caballus autosome (ECA) 1 to be associated
with hydrocephalus. Of the 99 SNPs that passed the
Bonferroni corrected significance level, most (n = 96)
were located on ECA1 (Fig. 1). SNPs significantly asso-
ciated with hydrocephalus in Friesian horses on ECA1
were located between 61 and 87 Mb (Additional file 2).
Six SNPs (BIEC2-28302, BIEC2-28459, BIEC2-28506,
BIEC2-28912, BIEC2-28931 and BIEC2-28955) were
most strongly associated (P = 5.64 × 10−17) with hydro-
cephalus in Friesian horses (Additional file 2). Geno-
type distribution of these 6 SNPs, as well as for almost
all SNPs significantly associated with hydrocephalus,
were consistent with an autosomal recessive mode of
inheritance of hydrocephalus (Additional file 2).
A display of SNP genotypes from 60 to 90 Mb on
ECA1 showed that homozygosity extended for 10.5 Mb
(from 65.9 to 76.4 Mb [29]) in 12 out of 13 cases (Fig. 2).
There were several overlapping regions of homozygosity
between all 13 cases (Fig. 2). One region displayed
homozygosity in all 13 cases and only one control. This
region was located at position 74,897,451–76,370,694
(1.47 Mb) and included 18 genes (Additional file 3). At
the point in time that we reached this stage, none of the
genes was a clear candidate for the hydrocephalus
phenotype observed in the Friesian horses.
DNA sequence analysis
A broad region surrounding the shared region of homo-
zygosity was analysed by sequencing the coding exons
and exon-intron junctions of the genes in the region
between position 59.6 and 78.0 Mb of ECA1 identified
on the Equus caballus reference genome assembly
EquCab2.0, annotation release 101. The region con-
tained 142 genes with 1453 coding exons (Additional
file 4). Two of the exons were skipped due to design
problems. A broad region was selected to circumvent
the risk of mapping artefacts because of phenocopies
in the group of cases. DNA sequence reads were gen-
erated of 4 cases and 6 controls. Of the reads, on
average 60 % was derived from the targeted region.
The average coverage of the region was 216 fold per
DNA sample, and ranged from 124 fold to 332 fold.
Of the variable positions found in the regions shared
Fig. 1 Manhattan plot of hydrocephalus in Friesian horses. Significance level based on genotype differences between cases (n = 13) and controls
(n = 69) using a χ2-test (2df). The horizontal line is the Bonferroni corrected significance level (P = 1.68 × 10−6)
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in a homozygous state by the 13 cases that were in-
cluded in the genome-wide analysis, 3 fitted the case–
control model for a recessive disorder (Additional file 5).
Two of these were known variations in the genes LYST
and NID1 (rs394520771 and rs394402493, respectively).
The variant in the gene coding for β-1,3-N-acetylgalac-
tosaminyltransferase 2 (B3GALNT2 [Ensembl:ENSE-
CAG00000013338]) was a very likely candidate for
the hydrocephalus phenotype. The mutation intro-
duced a stopcodon on ECA1:75,907,505 (exon 12),
Fig. 2 SNP genotypes from 60 to 90 Mb on ECA1 for cases (n = 13) and controls (n = 69). Hydrocephalus associated homozygous genotypes are
depicted by red, heterozygous genotypes by yellow, normal homozygous genotypes by green and missing genotypes by black. Each column
corresponds to one horse, each row corresponds to one SNP. The candidate mutation in B3GALNT2 is part of a region of 1.47 Mb in length
(range: 74,897,451–76,370,694) that is shared homozygous by all 13 cases and one control. The region of 1.47 Mb in length is shown in the
enlargement, where obligate carriers (dams of cases) are marked with a star
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c.1423C>T [GenBank:XM_001491545] corresponding
to p.Gln475* [GenBank:XP_001491595]. In humans, a
muscular dystrophy-dystroglycanopathy phenotype [MDD
GA11, MIM:615181] including hydrocephalus has re-
cently been associated with mutations in B3GALNT2 [30,
31]. The 4 affected Friesian horses were homozygous for
the nonsense allele, while one of the controls was
heterozygous and the others were homozygous for the
normal allele.
The 16 cases of Friesian horses with hydrocephalus
that were available for the validation were genotyped for
the mutation by Sanger DNA sequencing and all were
found homozygous (TT) (Additional file 1). None of the
healthy controls was homozygous for the mutation.
There were 32 heterozygotes (TC), including all 17
obligate carriers, and 36 horses were homozygous for
the normal allele (CC) (Fig. 3). These numbers do
not reflect the allele frequency in the population be-
cause the horses were not randomly selected. Healthy
controls descending from carrier sires were overrepre-
sented. No variations were observed by Sanger DNA
sequencing of exon 1 from B3GALNT2, which was not
covered by the next generation sequencing experiment.
Population screening
Out of 60 stallions that were genotyped using a commer-
cially available DNA test based on the B3GALNT2 muta-
tion, 8 (13.3 %) were carrier of the allele T. Out of 805
broodmares, 139 (17.3 %) were also carrier. As the tested
horses can be considered as a random sample of the popu-
lation, the estimated frequency of allele T in the Friesian
horse population is 0.085( = (8 + 139) / ((60 + 805) × 2)).
None of the tested (unaffected) horses were homozygous
for the mutation (TT).
Linkage disequilibrium
LD between the candidate mutation in B3GALNT2 and
surrounding SNPs was highest (0.929) for XM_0014
91545 c.1423C>T and BIEC2-32912 (Additional file 6).
This SNP is located 1.1 Mb away from B3GALNT2
and was significantly associated with hydrocephalus
(P = 6.13 × 10−17; Fig. 4). LD was 0.928 between the
mutation and the SNPs most significantly associated
with hydrocephalus (P = 5.64 × 10−17). However, the
distance between XM_001491545 c.1423C>T and the
closest of these SNPs was 6.1 Mb (Fig. 4).
Discussion
Hydrocephalus has been recognized in many species, in
both livestock, laboratory animals and pets [32–36]. The
autosomal recessive mutation responsible for a neuro-
pathic form of hydrocephalus has been identified in
Angus beef cattle (OMIA:000487-9913, Hydrocephalus
in Bos taurus). In mice, an autosomal recessive mutation
in HYDIN (hydrocephalus-inducing [Ensembl:ENSMUS
G00000059854]) causes a lethal form of a communicat-
ing hydrocephalus with a perinatal onset. A 2-bp dele-
tion in exon 15 results in a premature termination of the
protein [37]. The mode of inheritance of hydrocephalus
in Friesian horses appears to be autosomal recessive and
genetic heterogeneity was not observed within our sam-
ple of the population. In humans, however, genetic
heterogeneity of congenital hydrocephalus has been ob-
served. Mutations in several genes, both X-linked and
autosomal, are responsible for hydrocephalus. In the
current study, no genetic heterogeneity was observed for
hydrocephalus with all 16 affected Friesian horses being
homozygous for the same nonsense mutation in
B3GALNT2. The strongest indication that this mutation
causes the phenotype in Friesian horses is that the exact
same nonsense mutation was found homozygously in a
human muscular dystrophy patient with hydrocephalus
by Stevens et al. [30] (Fig. 5) [MIM:610194.0006 or
dbSNP:rs367543077]. Nine different mutations were ob-
served in the B3GALNT2 gene in 6 human patients with
muscular dystrophy-dystroglycanopathy with brain and
eye anomalies, type A, 11 (MDDGA11 [MIM:615181]).
Following Stevens et al., Hedberg et al. [31] identified 2
Fig. 3 DNA sequencing results of a case, obligate carrier and control.
The mutation in the gene B3GALNT2 that causes hydrocephalus in
Friesian horses. Fragments comprising exon 12 of the gene from
an affected foetus (= case), an obligate carrier and a control
horse were amplified by PCR and analysed by Sanger DNA
sequencing. The C>T mutation (arrow) changes the codon CAG
for glutamine into a premature TAG stop codon, truncating the
encoded protein by 26 amino acids. The nomenclature for the
mutation is c.1423C>T [GenBank:XM_001491545] corresponding
to p.Gln475* [GenBank:XP_001491595]
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novel mutations in B3GALNT2 in a 5-year-old girl
with milder clinical features (ataxia, spasticity, muscle
weakness) and brain abnormalities (e.g. cerebellar cysts)
detected using MRI. The syndrome was clinically some-
what variable and only 4 patients and 1 affected foetus
(from 3 families) displayed hydrocephalus [30, 31].
Searches of OMIM, OMIA, Ensembl and NCBI databases
have not revealed associations between B3GALNT2 and a
phenotype or disorder other than muscular dystrophy-
dystroglycanopathy in humans.
Two other missense variants were observed by next
generation sequencing that segregated with the hydro-
cephalus phenotype. Both these variations were anno-
tated in dbSNP by two laboratories and were observed
in Quarter horses and an undefined sample of horses.
One variation was located in LYST (rs394520771). Muta-
tions in this gene cause Chediak-Higashi syndrome
(MIM:214500) in humans, of which hydrocephalus is
not a characteristic. The other variation was located in
NID1 (rs394402493). Mice with knock-out mutations of
this gene do not display a phenotype.
A subset of congenital muscular dystrophies in humans
(including MDDGA11), called dystroglycanopathies, is
characterized by a reduced glycosylation of α-dystroglycan
(α-DG), which is an integral component of the dystrophin
glycoprotein complex. Dystroglycan is present in skeletal
muscle but also in many tissues like the brain, where it
has a multitude of functions such as morphogenesis and
early development [38]. Dystroglycanopathies are clinically
heterogeneous disorders and are often associated with
central nervous system pathology [39]. Mutations in
several genes have been associated with dystroglycanopa-
thies, although still in about half of the patients with dys-
troglycanopathy no mutation was found [40]. Results from
Stevens et al. [30] and Hedberg et al. [31] demonstrated
that B3GALNT2 is involved in the glycosylation of α-DG
and that mutations within this gene can cause muscular
dystrophy-dystroglycanopathy with muscle and brain
anomalies. In Friesian horses, muscular dystrophy was
never considered, because affected foals are often
stillborn and dystrophy was therefore not observed
clinically. Based on the findings from the macroscopic
and microscopic examination of 4 stillborn Friesian
foals with hydrocephalus, the most likely cause of
hydrocephalus in Friesian horses was considered to be an
abnormal narrowing (stenosis) of the jugular foramen [6].
Fig. 4 Regional association plot of the region (on ECA1) most significantly associated with hydrocephalus in Friesian horses. Significance level
based on genotype differences between cases (n = 13) and controls (n = 69) using a χ2-test (2df). The horizontal line is the genome-wide Bonferroni
corrected significance level (P = 1.68 × 10−6). Location of the B3GALNT2 gene [Ensembl:ENSECAG00000013338] is indicated by the black cross. SNPs
surrounding B3GALNT2 are coloured in diminishing red to reflect LD (pair-wise r2 values) between the candidate mutation in B3GALNT2 and SNPs. LD
calculations between the mutation and the surrounding SNPs are based on genotypes for the mutation of 13 cases, 45 controls and 3 dams of cases
and on SNP genotypes of all 13 cases and 69 controls
Fig. 5 Conservation of the C-terminal end of the B3GALNT2 protein between horse and man. The depicted 44 amino acid sequence is encoded
by exon 12 of the gene in the horse. Identical amino acids in man are indicated by a dot. The point of truncation in Friesian horses with hydrocephalus
and a human patient with muscular dystrophy-dystroglycanopathy type A, 11 [30] is indicated by an asterisk. E.caballus = horse, H.sapiens = human
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Because the exact same nonsense mutation of B3GALNT2
found in Friesian horses was also present in a MDDGA11
human patient with hydrocephalus, the same complex as
in humans (including muscular dystrophy) might underlie
the phenotype observed in Friesian horses. A subsequent
immunohistochemical examination of muscle biopsies
from hydrocephalus cases might determine whether these
cases suffer from muscular dystrophy as well.
The genome-wide association study identified a region
on ECA1 highly associated with hydrocephalus. Due to
the autosomal recessive mode of inheritance for hydro-
cephalus in Friesian horses, the 2 × 3 tables to test differ-
ences in genotype frequencies between cases and
controls for most of the significantly associated SNPs
contained cell(s) with zero observations. Therefore, the
Fisher’s exact test would have been a more suitable test
to use compared to the applied χ2-test. Although the cal-
culated significance level between these two tests could
differ, the same region on ECA1 was still found to be
strongly associated with hydrocephalus when applying
the Fisher’s exact test. We illustrated that indeed the
identification of a region associated with a phenotype in
a population with reasonable inbreeding (and LD) is
feasible. However, fine-mapping was hampered. Within
such populations, a sufficiently large region surrounding
the significantly associated SNPs should be sequenced to
be able to identify the causal mutation. Most of the
highly significantly associated SNPs (except BIEC2-32912)
were located more than 6 Mb away from B3GALNT2
(ECA1:75,859,296-75,909,376). Also, the homozygosity in
12 out of 13 cases extended over several mega base pairs
(≥10.5 Mb; Fig. 2). There were several overlapping regions
of homozygosity between all 13 cases (Fig. 2), but these
regions were shared in a homozygous state by 4 or more
controls. However, there was one region of 1.47 Mb in
length (from 74,897,451 to 76,370,694 bp, Equus caballus
EquCab2.0 reference genome [29], Fig. 2), where all 13
cases and only one of the controls were homozygous for
the hydrocephalus associated allele that was defined by 16
consecutive SNPs. The candidate gene B3GALNT2 is lo-
cated within this region of 1.47 Mb and the genotype of
the one homozygous control at the presumed causal
mutation was TC. Homozygosity mapping indicated a
recombination event close to the mutation in B3GALNT2,
as one out of 13 cases did not show the entire 10.5 Mb
region as identical-by-state. Therefore, hydrocephalus in
Friesian horses presumably is caused by a recent mutation
on ECA1 that occurred in this breed.
The subsequent genotyping of Friesian horses for the
mutation will identify carriers in unaffected horses. Ex-
clusion of carriers from breeding will be the fastest way
to diminish hydrocephalus incidence. However, exclusion
of all carriers will likely not be a sound strategy for this
population as inbreeding is reasonable [1]. Inbreeding can
increase faster when carriers are excluded. For now,
breeders are informed about the mutation status (carrier/
non-carrier) of newly approved young stallions and can
voluntarily test their own mares. Mating 2 carriers should
be avoided. Other measures, such as testing of embryos
before implantation may be feasible, but this is currently
not commonly practiced yet in Friesian horses.
Conclusions
A nonsense mutation in B3GALNT2 is concordant with
hydrocephalus in Friesian horses, which has an auto-
somal recessive mode of inheritance. A genome-wide as-
sociation study and homozygosity mapping identified a
region on ECA1 highly associated with hydrocephalus.
Subsequent analysis of sequence data identified a puta-
tive causal mutation, which was successfully validated in
both affected and unaffected Friesian horses. Carriers
among unaffected horses can be identified and the appli-
cation of this knowledge in the breeding programme will
thus reduce the losses caused by hydrocephalus in the
Friesian horse population.
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